WADI SUKI

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address2256 Holcombe Blvd
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01DK037543     (SUKI, WADI N.)Sep 1, 1986 - Aug 31, 1991
    NIH/NIDDK
    CALCIUM AND EPITHELIAL TRANSPORT
    Role: Principal Investigator

    R09RG014274     (SUKI, WADI N.)Jul 1, 1983 - Jun 30, 1985
    NIH/CSR
    GENERAL MEDICINE B STUDY SECTION
    Role: Principal Investigator

    R01AM021394     (SUKI, WADI N.)Sep 30, 1978 - Dec 31, 1987
    NIH/NIADDK
    NEPHRONAL SITES OF DIVALENT ION TRANSPORT
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Frost AE, Moore LW, Valdivia E Alvarado M, Obi C, Graviss EA, Nguyen DT, Gaber AO, Suki WN. The echocardiographic course of pretransplant pulmonary hypertension following kidney transplantation and associated outcomes. Pulm Circ. 2022 Jan; 12(1):e12030. PMID: 35506107; PMCID: PMC9052995.
      Citations: 1     
    2. Swan JT, Iso T, Rizk E, Trachtenberg BH, Krisl J, Varnado S, Suki WN, Frost AE, Suarez E, Uddin FS, Kassi M, Giesecke NM, Bhimaraj A, Masud FN. Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation. ASAIO J. 2022 01 01; 68(1):46-55. PMID: 34227791.
      Citations:    Fields:    Translation:Humans
    3. Swan JT, Moore LW, Sparrow HG, Frost AE, Gaber AO, Suki WN. Optimization of Acute Kidney Injury (AKI) Time Definitions Using the Electronic Health Record: A First Step in Automating In-Hospital AKI Detection. J Clin Med. 2021 Jul 27; 10(15). PMID: 34362089; PMCID: PMC8347988.
      Citations:    
    4. Abdelrahim M, Mamlouk O, Lin H, Lin J, Page V, Abdel-Wahab N, Swan J, Selamet U, Yee C, Diab A, Suki W, Abudayyeh A. Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis. Oncoimmunology. 2021 05 23; 10(1):1927313. PMID: 34104543; PMCID: PMC8158025.
      Citations: 1     Fields:    Translation:Humans
    5. Gaber LW, Khan FN, Graviss EA, Nguyen DT, Moore LW, Truong LD, Barrios RJ, Suki WN. Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys. Kidney Int Rep. 2020 Nov; 5(11):1914-1924. PMID: 33163712; PMCID: PMC7609995.
      Citations: 3     
    6. Obi C, Frost AE, Graviss EA, Nguyen DT, Gaber AO, Suki WN. The Association of Pretransplant Pulmonary Hypertension With Patient and Graft Survival After Kidney Transplantation: A Retrospective Cohort Study. Transplant Proc. 2020 Dec; 52(10):3023-3032. PMID: 32665088.
      Citations: 3     Fields:    Translation:Humans
    7. Khan FN, Truong LD, Nguyen DT, Graviss EA, Bhatti MI, Frost AE, Osama Gaber A, Suki WN. Outcomes of kidney transplantation using deceased donors with history of diabetes. Clin Transplant. 2020 02; 34(2):e13775. PMID: 31863607.
      Citations: 1     Fields:    Translation:Humans
    8. Truong LD, Suki WN, Gaber LW, Gaber OA, Khan F. Kidney Donors With Diabetes: Renal Biopsy Findings at Time of Transplantation and Their Significance. Transplant Direct. 2019 Jul; 5(7):e465. PMID: 31334339; PMCID: PMC6616142.
      Citations: 1     
    9. Brito RM, Nguyen DT, Johnson JR, Lai EJ, Castro RE, Albert AM, Barnes AS, Graviss EA, Suki WN. Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort. PLoS One. 2019; 14(4):e0215575. PMID: 30995263; PMCID: PMC6469809.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    10. Sparrow HG, Swan JT, Moore LW, Gaber AO, Suki WN. Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1. Kidney Int. 2019 04; 95(4):905-913. PMID: 30819553.
      Citations: 10     Fields:    Translation:Humans
    11. Moore LW, Suki WN, Lunsford KE, Sabek OM, Knight RJ, Gaber AO. Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults. BMJ Open. 2019 02 22; 9(2):e022471. PMID: 30798303; PMCID: PMC6398648.
      Citations:    Fields:    Translation:Humans
    12. Rossitter CW, Vigo RB, Gaber AO, Swan JT, Suki WN. Evaluation of Carotid Ultrasonography Screening Among Kidney Transplant Candidates: A Single-Center, Retrospective Study. Transplant Direct. 2017 Mar; 3(3):e135. PMID: 28361119; PMCID: PMC5367752.
      Citations:    
    13. Suki WN, Moore LW. Phosphorus Regulation in Chronic Kidney Disease. Methodist Debakey Cardiovasc J. 2016 Oct-Dec; 12(4 Suppl):6-9. PMID: 28298956; PMCID: PMC5347182.
      Citations: 6     Fields:    Translation:Humans
    14. Patel SJ, Suki WN, Loucks-DeVos J, Graviss EA, Nguyen DT, Knight RJ, Kuten SA, Moore LW, Teeter LD, Gaber LW, Gaber AO. Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction. Transpl Int. 2016 Aug; 29(8):897-908. PMID: 27196395.
      Citations: 3     Fields:    Translation:Humans
    15. Moore LW, Nolte JV, Gaber AO, Suki WN. Association of dietary phosphate and serum phosphorus concentration by levels of kidney function. Am J Clin Nutr. 2015 Aug; 102(2):444-53. PMID: 26040641.
      Citations: 24     Fields:    Translation:HumansAnimalsCTClinical Trials
    16. Gaber AO, Moore LW, Aloia TA, Suki WN, Jones SL, Graviss EA, Knight RJ, Bass BL. Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery. Ann Surg. 2013 Jul; 258(1):169-77. PMID: 23478526.
      Citations: 18     Fields:    Translation:Humans
    17. Jantz AS, Patel SJ, Suki WN, Knight RJ, Bhimaraj A, Gaber AO. Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients. Case Rep Transplant. 2013; 2013:375263. PMID: 23844312; PMCID: PMC3697147.
      Citations: 2     
    18. Weinman EJ, Light PD, Suki WN. Gastrointestinal phosphate handling in CKD and its association with cardiovascular disease. Am J Kidney Dis. 2013 Nov; 62(5):1006-11. PMID: 23769135; PMCID: PMC3779494.
      Citations: 3     Fields:    Translation:Humans
    19. DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int. 2012 Sep; 82(5):598-604. PMID: 22622504.
      Citations: 36     Fields:    Translation:Humans
    20. Soltero L, Carbajal H, Xu J, McCarthy J, Suki WN, Gaber AO, Adrogu? HE. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy. Clin Transplant. 2012 Mar-Apr; 26(2):300-4. PMID: 22044717.
      Citations: 4     Fields:    Translation:Humans
    21. Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clin Transplant. 2011 May-Jun; 25(3):E250-6. PMID: 21231963.
      Citations: 8     Fields:    Translation:HumansAnimals
    22. Ohta K, Suki WN, Takaba J, Miyamoto H, Nos? Y. Introduction of new technologies for the treatment of diabetic complications: cryoreactive albumin removal apheresis. Artif Organs. 2011 Jan; 35(1):4-8. PMID: 21226744.
      Citations:    Fields:    Translation:HumansCells
    23. Dawson KL, Patel SJ, Putney D, Suki WN, Osama Gaber A. Cardioprotective medication use after renal transplantation. Clin Transplant. 2010 Nov-Dec; 24(6):E253-6. PMID: 20553301.
      Citations: 2     Fields:    Translation:Humans
    24. Kadikoy H, Paolini M, Achkar K, Suki W, Gaber AO, Anwar N, Jeroudi A, Barrios R, Abdellatif A. Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus. Nephrol Dial Transplant. 2010 Aug; 25(8):2795-8. PMID: 20484303.
      Citations: 8     Fields:    Translation:Humans
    25. Fishbane S, Delmez J, Suki WN, Hariachar SK, Heaton J, Chasan-Taber S, Plone MA, Moe S. A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis. Am J Kidney Dis. 2010 Feb; 55(2):307-15. PMID: 20042256.
      Citations: 11     Fields:    Translation:Humans
    26. Raghavan R, Jeroudi A, Achkar K, Suki W, Gaber AO, Knight R, Land G, Dilioglou S, Patel S, Abdellatif A. Bortezomib in kidney transplant desensitization: a case report. Clin Transpl. 2009; 339-42. PMID: 20524295.
      Citations: 7     Fields:    Translation:HumansCells
    27. Suki WN, Dialysis Clinical Outcomes Revisited Investigators. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial. J Ren Nutr. 2008 Jan; 18(1):91-8. PMID: 18089452.
      Citations: 19     Fields:    Translation:Humans
    28. Patel SJ, Samo TC, Suki WN. Early-onset rhabdomyolysis related to daptomycin use. Int J Antimicrob Agents. 2007 Nov; 30(5):472-4. PMID: 17804204.
      Citations: 6     Fields:    Translation:Humans
    29. Akgun H, Ozcan A, Chirala M, Zhai J, Shen SS, Suki WN, Truong LD. Lymphoid cell proliferation in renal transplants: biologic and diagnostic implications. Clin Transplant. 2007 Jul-Aug; 21(4):472-80. PMID: 17645706.
      Citations: 1     Fields:    Translation:HumansCells
    30. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, DRIVE Study Group. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007 Mar; 18(3):975-84. PMID: 17267740.
      Citations: 113     Fields:    Translation:Humans
    31. Akgun H, Gonlusen G, Cartwright J, Suki WN, Truong LD. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med. 2006 Sep; 130(9):1354-7. PMID: 16948524.
      Citations: 21     Fields:    Translation:Humans
    32. Adrogue HE, Soltero L, Land GA, Ramanathan V, Truong LD, Suki WN. Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft. Transplantation. 2006 Aug 27; 82(4):567-9. PMID: 16926602.
      Citations: 4     Fields:    Translation:HumansCells
    33. Ramanathan V, Suki WN, Rosen D, Truong LD. Chronic allograft nephropathy and nephrotic range proteinuria. Clin Transplant. 2005 Jun; 19(3):413-7. PMID: 15877807.
      Citations: 1     Fields:    Translation:Humans
    34. Soltero L, Carbajal H, Sarkissian N, Khan AJ, Brennan S, Gonzalez JM, Truong LD, Suki WN. A truncated-dose regimen of daclizumab for prevention of acute rejection in kidney transplant recipients: a single-center experience. Transplantation. 2004 Nov 27; 78(10):1560-3. PMID: 15599323.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    35. Truong LD, Yakupoglu U, Feig D, Hicks J, Cartwight J, Sheikh-Hamad D, Suki WN. Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications. Am J Transplant. 2004 Aug; 4(8):1338-44. PMID: 15268737.
      Citations: 14     Fields:    Translation:HumansCells
    36. Yakupoglu U, Baranowska-Daca E, Rosen D, Barrios R, Suki WN, Truong LD. Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int. 2004 Jun; 65(6):2360-70. PMID: 15149349.
      Citations: 7     Fields:    Translation:Humans
    37. Saikali JA, Truong LD, Suki WN. Sirolimus may promote thrombotic microangiopathy. Am J Transplant. 2003 Feb; 3(2):229-30. PMID: 12603218.
      Citations: 8     Fields:    Translation:Humans
    38. Truong LD, Baranowska-Daca E, Ly PD, Tsao CC, Zafarmand AA, Suki WN. The remission of post-transplant nephrotic syndrome clinicopathologic characterization. Am J Transplant. 2002 Nov; 2(10):975-82. PMID: 12482152.
      Citations:    Fields:    Translation:Humans
    39. Zafarmand AA, Baranowska-Daca E, Ly PD, Tsao CC, Choi YJ, Suki WN, Truong LD. De novo minimal change disease associated with reversible post-transplant nephrotic syndrome. A report of five cases and review of literature. Clin Transplant. 2002 Oct; 16(5):350-61. PMID: 12225432.
      Citations: 6     Fields:    Translation:Humans
    40. Choi YJ, Mendoza L, Rha SJ, Sheikh-Hamad D, Baranowska-Daca E, Nguyen V, Smith CW, Nassar G, Suki WN, Truong LD. Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice. J Am Soc Nephrol. 2001 May; 12(5):983-992. PMID: 11316857.
      Citations: 11     Fields:    Translation:AnimalsCells
    SUKI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (201)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _